/
Grants360°: DoD Grants
Edit

Grants360°: DoD Grants

Elizabeth Platz, Professor in the Department of Epidemiology, Nicole Baumgarth Professor in the Department of Molecular Microbiology and Immunology, and Vito Rebecca, Assistant Professor in the Department of Biochemistry and Molecular Biology discuss their experience applying for and obtaining a CDMRP grant and their recommendations and advice for investigators interested in a CDMRP opportunity. Dean Emeritus Ellen MacKenzie, Professor in the Department of Health Policy and Management, joined to reflect on her DoD-funded research career.

Overview

The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) is a highly competitive federal funding program that supports innovative, high-impact biomedical and health research in areas specifically designated by Congress. Unlike traditional investigator-initiated research programs, CDMRP emphasizes transformative, patient-centered research with the potential to accelerate prevention, diagnosis, treatment, and cures for diseases and conditions affecting military personnel, veterans, and the general public. The program spans more than 35 research areas and funds projects across the full research spectrum, from basic discovery through clinical trials. A distinguishing feature of CDMRP is its two-tier review process, which combines rigorous scientific peer review with programmatic review that considers portfolio balance, military relevance, and patient impact. Awards are available to investigators at universities, medical centers, nonprofits, and industry, with funding mechanisms tailored to early-career investigators, established researchers, multidisciplinary teams, and translational research initiatives.

DoD CDMRP Application & Review Process:

Funding Opportunities are Mission-Driven

  • Unlike NIH where investigators largely propose their own research ideas, CDMRP funding announcements identify specific research priorities and focus areas that applicants must address.

  • Priorities, mechanisms, and eligibility criteria can change substantially from year to year, so investigators should carefully review each annual funding announcement rather than relying on previous cycles.

Pre-Application Stage

  • Many mechanisms require a pre-proposal (or occasionally a LOI) before a full application.

  • Depending on the mechanism, the pre-proposal may serve as an eligibility and programmatic fit assessment, undergo formal review and selection before applicants are invite to submit a full proposal, and be as short as a two-page concept summary with biosketches, although requirements vary by program.

  • Some mechanisms have become increasingly selective at the pre-application stage.

Full Application Requirements

  • Compared with an NIH R01, CDMRP applications require several additional components:

    • Scientific research narrative

    • Detailed Statement of Work (SOW)

    • Technical abstract

    • Lay abstract

    • Impact statement

    • Data management plan

    • Transition/Translation plan describing how findings will advance toward implementation, policy, commercialization, or future research.

  • Panelists emphasized that the proposal structure differs substantially from NIH applications and requires reorganizing the scientific story rather than simply reusing an NIH proposal.

  • The Statement of Work (SOW) is considered one of the most important and challenging components. It must:

    • Outline every major task and subtask

    • Include detailed timelines

    • Specify personnel responsibilities

    • Define expected deliverables

    • Serve as the primary document used by program officers to evaluate project progress after award.

  • Unlike NIH applications, investigators are expected to commit to a highly structured work plan that closely guides both project execution and reporting.

Review Process:

  • Applications undergo a two-stage review process:

    • Scientific Peer Review: evaluated by multidisciplinary scientific reviews. Panels intentionally include experts from diverse disciplines rather than narrowly focused study sections.

    • Programmatic Review (Integration Panel): highly scored applications move to a second review. Programmatic panels consider scientific merit, program priorities, portfolio balance, and potential impact.

  • A distinguishing feature of CDMRP is the prominent role of consumer reviewers (patient advocates or community representatives), who participate in both scientific review and programmatic decision-making and have substantial influence on funding recommendations.

  • Because consumer reviewers participate throughout the review process, lay abstracts are important. Investigators must clearly explain:

    • Why the research matters

    • How patients or affected populations will benefit

    • The potential real-world impact

  • Successful applications communicate effectively to both scientific and non-scientific audiences.

  • Typical timelines reported include:

    • Pre-proposal or LOI submission (when required)

    • Full application submission

      • Peer review within approximately 2-3 months

      • Funding decisions generally within 7-8 months after submissions, though timelines vary by mechanism.

      • If selected for funding, investigators often enter negotiations regarding the final SOW before award issuance.

Award Compliance and Post-Award Management:

  • Before research can begin, awardees must complete additional compliance requirements include:

    • Separate IRB or IACUC protocols specifically tied to the DoD award.

    • Additional DoD review and approval (e.g., ACURO for animal studies or DoD human subjects review).

    • Research cannot begin until both institutional and DoD approvals are complete.

  • After funding:

    • Progress reports must align directly with the approved SOW

    • Reporting may be quarterly or annual, depending on the mechanism

    • Required templates and formats are strictly enforced.

    • While administrative requirements are detailed, PO’s are collaborative and flexible when scientific adjustments become necessary.

Award Impact:

  • DoD funding helped investigators establish their laboratories, build research programs, gain national visibility, and develop valuable collaborations.

  • Award mechanisms encouraged partnerships across disciplines, resulting in stronger research teams and expanded scientific networks.

  • Investigators noted that CDMRP supports bold, early-stage ideas that may be difficult to fund through traditional NIH mechanisms.

  • DoD-funded projects generated preliminary data that helped investigators secure subsequent NIH R01 and other competitive awards.

  • Awards led to important discoveries, globally used research resources, and shared tools that benefited the broader scientific community.

  • Successful projects addressed critical research gaps while emphasizing translation to improved patient outcomes, military readiness, and public health impact.

  • Panelists described DoD funding as a valuable complement to NIH support, helping diversify research funding and encouraging investigators to pursue innovative, translational research.

Resource Links

Recording

Grants360: DoD Session

 

We are always working to provide our faculty with current precise content. If you have brief suggestions to help us improve this page please comment below. For more extensive modifications please connect with us at BSPH.research@jhu.edu.